health
Kidney Stone Formation Risk
Adverse effectKidney stone formation risk is the possibility that solid stones may develop in the kidneys or urinary system. It is an adverse health outcome, not a confirmation that stones are present and not a measure of how severe they are.
A focused starting point for understanding the health concept of Kidney Stone Formation Risk.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Hot YogapracticeUnclear
Based on one study.
Repeated sweating without adequate fluid intake can cause chronic dehydration, increasing urinary concentration and the risk of calcium oxalate stone formation.
Open the Hot Yoga pageChagasupplementUnclear
Based on one study.
Some Chaga preparations contain very high oxalate levels, which can increase urinary oxalate and promote calcium oxalate crystallization, kidney stones, or oxalate nephropathy.
Open the Chaga pageFastingpracticeUnclear
Based on one study.
A pharmacology reference notes that dehydration and reduced citrate excretion during prolonged fasting can increase the risk of calcium oxalate kidney stone formation.
Open the Fasting pageIV Vitamin DrippracticeUnclear
Based on one study.
High-dose IV Vitamin C is metabolized to oxalate, increasing urinary oxalate excretion and the risk of calcium oxalate kidney stones.
Open the IV Vitamin Drip page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on4 listedHighest probability
- →PracticesHot YogaCertaintyLowSourceReference knowledge1 other source
Repeated sweating without adequate fluid intake can cause chronic dehydration, increasing urinary concentration and the risk of calcium oxalate stone formation.
Open Hot YogaStudy result
Chronic dehydration from repeated sweating without adequate fluid intake increases urinary concentration and risk of calcium oxalate stone formation.
- →SupplementsChagaCertaintyLowSourceReference knowledge1 other source
Some Chaga preparations contain very high oxalate levels, which can increase urinary oxalate and promote calcium oxalate crystallization, kidney stones, or oxalate nephropathy.
Open ChagaStudy result
Chaga's high oxalate content can promote calcium oxalate kidney stone formation, especially with prolonged high-dose use.
- →PracticesFastingCertaintyLowSourceReference knowledge1 other source
A pharmacology reference notes that dehydration and reduced citrate excretion during prolonged fasting can increase the risk of calcium oxalate kidney stone formation.
Open FastingStudy result
Dehydration and reduced citrate excretion during prolonged fasting increase the risk of calcium oxalate kidney stone formation.
- →PracticesIV Vitamin DripCertaintyLowSourceReference knowledge1 other source
High-dose IV Vitamin C is metabolized to oxalate, increasing urinary oxalate excretion and the risk of calcium oxalate kidney stones.
Open IV Vitamin DripStudy result
High-dose IV vitamin C is metabolized to oxalate, increasing urinary oxalate excretion and risk of calcium oxalate kidney stones.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Kidney stone formation risk is the possibility that solid stones may develop in the kidneys or urinary system. It is an adverse health outcome, not a confirmation that stones are present and not a measure of how severe they are. Evidence linked with this outcome includes findings involving interventions such as Calcium, Panax Ginseng, Caffeine, and Chaga, but each association should be interpreted on its own.
How interventions help
These interventions do not appear to influence kidney stone formation through one shared pathway. Some can raise urinary calcium, including caffeine, high protein intake from Whey Protein, and high-dose Zinc. Others may increase urinary oxalate, which is relevant to calcium oxalate crystallization; examples include some Chaga preparations, large supplemental loads of Collagen, high-dose Cranberry Extract, oxalate-containing Curcumin formulations, high-dose Quercetin, and high-oxalate Beetroot Extract. Spirulina may instead increase uric acid production, while sustained high-dose MCT Oil regimens are described in relation to hypocitraturia, hypercalciuria, and low urine pH. These differences mean that the relevant concern depends partly on the type of stone risk and an individual's susceptibility.
The timing also varies in the descriptions. Some concerns are specifically associated with sustained, long-term, or high-dose use, rather than a single exposure. The information does not establish a specific onset time or whether any increased risk persists after stopping. Several findings emphasize people who are susceptible or predisposed, including those with a history of calcium oxalate stones, so the same intervention may not carry the same relevance for everyone.
Calcium, Panax Ginseng, Sodium Bicarbonate, and Vitamin C are represented as associations with kidney stone outcomes, but the available descriptions do not provide a shared mechanism or enough detail to explain how those associations differ. Sodium Bicarbonate and Vitamin C are specifically linked with very low-probability findings, while other interventions are described through potential urinary changes or composition-related mechanisms.
Choosing guidance
Choosing among these options depends first on personal susceptibility to stones and on the type of urinary change involved. Several concerns relate to increased urinary oxalate, while others involve urinary calcium, uric acid, urine pH, or citrate. This makes the relevant risk different for someone predisposed to calcium oxalate stones than for someone predisposed to uric acid stones. A history of stones, particularly calcium oxalate stones, is specifically relevant to some of the listed concerns.
The evidence is not equally direct. Some options have clinical evidence from human research, whereas others are supported by pharmacology references or theoretical reasoning rather than direct clinical testing. The clinical findings also do not establish that all options carry the same type or magnitude of risk, and the evidence may not apply equally to people with different health statuses.
The presented information does not provide comparable doses or a consistent time period for use, so it cannot show how much is needed to produce a concern or rank options by risk at a particular intake. It does indicate that some concerns are associated with high-dose, large, sustained, chronic, or long-term use, while repeated dehydration during long rides is a distinct context. How quickly a risk might appear is not established here.
For someone with a history of stones or another stated predisposition, options linked to oxalate, urinary calcium, uric acid, or changes in urine chemistry warrant closer consideration than they might for someone without that susceptibility. Where evidence comes mainly from reference-based or theoretical reasoning, uncertainty is greater and should be acknowledged rather than treated as a confirmed clinical effect.